Annual Retained Earnings
-$53.22 M
-$14.58 M-37.73%
December 31, 2023
Summary
- As of February 7, 2025, ACXP annual retained earnings is -$53.22 million, with the most recent change of -$14.58 million (-37.73%) on December 31, 2023.
- During the last 3 years, ACXP annual retained earnings has fallen by -$39.42 million (-285.63%).
- ACXP annual retained earnings is now -478.43% below its all-time high of -$9.20 million, reached on December 31, 2019.
Performance
ACXP Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Retained Earnings
-$64.54 M
-$2.82 M-4.57%
September 30, 2024
Summary
- As of February 7, 2025, ACXP quarterly retained earnings is -$64.54 million, with the most recent change of -$2.82 million (-4.57%) on September 30, 2024.
- Over the past year, ACXP quarterly retained earnings has dropped by -$16.44 million (-34.17%).
- ACXP quarterly retained earnings is now -367.66% below its all-time high of -$13.80 million, reached on December 31, 2020.
Performance
ACXP Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Retained Earnings Formula
Retained Earnings = Retained Earnings (start of the period) + Net Income − Dividends Paid
ACXP Retained Earnings Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -37.7% | -34.2% |
| 3 y3 years | -285.6% | -43.5% |
| 5 y5 years | -478.4% | -43.5% |
ACXP Retained Earnings Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -100.5% | at low | -67.0% | at low |
| 5 y | 5-year | -478.4% | at low | -367.7% | at low |
| alltime | all time | -478.4% | at low | -367.7% | at low |
Acurx Pharmaceuticals Retained Earnings History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -$64.54 M(+4.6%) |
| Jun 2024 | - | -$61.72 M(+7.2%) |
| Mar 2024 | - | -$57.60 M(+8.2%) |
| Dec 2023 | -$53.22 M | -$53.22 M(+10.6%) |
| Sep 2023 | - | -$48.10 M(+6.9%) |
| Jun 2023 | - | -$44.99 M(+8.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2023 | - | -$41.54 M(+7.5%) |
| Dec 2022 | -$38.64 M(+45.6%) | -$38.64 M(+153.0%) |
| Dec 2021 | -$26.55 M(+92.4%) | - |
| Mar 2021 | - | -$15.27 M(+10.7%) |
| Dec 2020 | -$13.80 M(+50.0%) | -$13.80 M |
| Dec 2019 | -$9.20 M | - |
FAQ
- What is Acurx Pharmaceuticals annual retained earnings?
- What is the all time high annual retained earnings for Acurx Pharmaceuticals?
- What is Acurx Pharmaceuticals annual retained earnings year-on-year change?
- What is Acurx Pharmaceuticals quarterly retained earnings?
- What is the all time high quarterly retained earnings for Acurx Pharmaceuticals?
- What is Acurx Pharmaceuticals quarterly retained earnings year-on-year change?
What is Acurx Pharmaceuticals annual retained earnings?
The current annual retained earnings of ACXP is -$53.22 M
What is the all time high annual retained earnings for Acurx Pharmaceuticals?
Acurx Pharmaceuticals all-time high annual retained earnings is -$9.20 M
What is Acurx Pharmaceuticals annual retained earnings year-on-year change?
Over the past year, ACXP annual retained earnings has changed by -$14.58 M (-37.73%)
What is Acurx Pharmaceuticals quarterly retained earnings?
The current quarterly retained earnings of ACXP is -$64.54 M
What is the all time high quarterly retained earnings for Acurx Pharmaceuticals?
Acurx Pharmaceuticals all-time high quarterly retained earnings is -$13.80 M
What is Acurx Pharmaceuticals quarterly retained earnings year-on-year change?
Over the past year, ACXP quarterly retained earnings has changed by -$16.44 M (-34.17%)